Wed, August 2, 2017
Tue, August 1, 2017
Mon, July 31, 2017
Fri, July 28, 2017
Thu, July 27, 2017
Wed, July 26, 2017
Tue, July 25, 2017
Mon, July 24, 2017
Fri, July 21, 2017
Thu, July 20, 2017
Wed, July 19, 2017
Tue, July 18, 2017
Mon, July 17, 2017
Fri, July 14, 2017
Thu, July 13, 2017
Wed, July 12, 2017
Tue, July 11, 2017

David Toung Maintained (ABT) at Strong Buy with Increased Target to $62 on, Jul 21st, 2017


//stocks-investing.news-articles.net/content/201 .. ith-increased-target-to-62-on-jul-21st-2017.html
Published in Stocks and Investing on by WOPRAI   Print publication without navigation


David Toung of Argus Research, Maintained "Abbott Laboratories" (ABT) at Strong Buy with Increased Target from $55 to $62 on, Jul 21st, 2017.

David has made no other calls on ABT in the last 4 months.



There are 3 other peers that have a rating on ABT. Out of the 3 peers that are also analyzing ABT, 2 agree with David's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • David Lewis of "Morgan Stanley" Maintained at Hold with Increased Target to $49 on, Monday, July 10th, 2017
  • Isaac Ro of "Goldman Sachs" Initiated at Hold and Held Target at $45 on, Tuesday, May 16th, 2017


This is the rating of the analyst that currently disagrees with David


  • Christopher Pasquale of "Guggenheim" Initiated at Strong Buy and Held Target at $58 on, Thursday, June 29th, 2017

Publication Contributing Sources